EU Reaffirms Rejection of Rare Sleep Disorder Drug

by | Mar 30, 2026 | Health

The sleep drug failed to gain approval for nighttime disruptions in children with a rare genetic disorder affecting circadian rhythm patterns.
Medscape News Europe

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments